|
Attorneys are seeing a rise in Aleve lawsuits after the U.S. Food
and Drug Administration announced in December 2004 that the National
Institutes of Health had halted a study involving Naproxen, commonly
used in the brand name over-the-counter pain medication Aleve.
According to Aleve lawsuits, during the study, researchers found
Naproxen, a nonsteroidal anti-inflammatory drug (NSAID) used to
treat pain associated with arthritis, gout, and other joint
disorders, increased the risk of heart attacks and strokes.
According to Aleve lawsuit attorneys, patients taking Aleve may
increase their risk of Naproxen and Aleve-related heart attacks and
strokes by up to 50%. The FDA suggests that patients not exceed the
recommended daily dosage of Aleve, and should not take the product
for more than 10 days.
An Aleve lawsuit may be necessary if you or a loved one used the
medication and suffered a heart attack or stroke. NSAIDs are under
an intense review by health officials after cox-2 selective NSAIDs
Vioxx, Celebrex and Bextra were linked to serious cardiovascular
events. Vioxx was withdrawn from the U.S. and worldwide market in
September 2004. In addition, it may be important to contact an Aleve
lawsuit attorney who can help you protect your legal rights. Please
keep in mind that there may be time limits within which you must
commence an Aleve lawsuit.
DRUG INTERACTIONS:
Naproxen is associated with several
suspected or probable interactions that affect the action of other
drugs. The following examples are the most common suspected
interactions.
Naproxen may increase the blood levels
of lithium by reducing the excretion of lithium by the kidneys.
Increased levels of lithium may lead to lithium toxicity.
Naproxen may reduce the blood pressure
lowering effects of blood pressure medications.
When naproxen is used in combination
with aminoglycosides (e.g., gentamicin) the blood levels of the
aminoglycoside may increase.
Individuals taking oral blood thinners
or anticoagulants should avoid naproxen because naproxen also thins
the blood, and excessive blood thinning may lead to bleeding.
PREGNANCY:
There are no adequate studies of naproxen in pregnant women.
Therefore, naproxen is not recommended during pregnancy.
NURSING MOTHERS:
Most NSAIDs, including naproxen, are excreted in breast milk. In
general, breast feeding mothers should avoid the use of NSAIDs. |